Author
Listed:
- Zenggang Li
(Emory University)
- Andrei A. Ivanov
(Emory University)
- Rina Su
(Emory University
Xiangya Hospital, Central South University
Beijing Chao-yang Hospital, Capital Medical University)
- Valentina Gonzalez-Pecchi
(Emory University)
- Qi Qi
(Emory University)
- Songlin Liu
(Emory University
Xiangya Hospital, Central South University)
- Philip Webber
(Emory University)
- Elizabeth McMillan
(University of Texas Southwestern Medical Center)
- Lauren Rusnak
(Emory University)
- Cau Pham
(Emory University)
- Xiaoqian Chen
(Emory University
School of Basic Medicine, Huazhong University of Science and Technology)
- Xiulei Mo
(Emory University)
- Brian Revennaugh
(Emory University)
- Wei Zhou
(Emory University
Winship Cancer Institute, Emory University)
- Adam Marcus
(Emory University
Winship Cancer Institute, Emory University)
- Sahar Harati
(Emory University School of Medicine)
- Xiang Chen
(Xiangya Hospital, Central South University)
- Margaret A. Johns
(Emory University)
- Michael A. White
(University of Texas Southwestern Medical Center)
- Carlos S. Moreno
(Winship Cancer Institute, Emory University
Emory University School of Medicine
Emory University School of Medicine)
- Lee A. D. Cooper
(Winship Cancer Institute, Emory University
Emory University School of Medicine
Georgia Institute of Technology/Emory University School of Medicine)
- Yuhong Du
(Emory University
Winship Cancer Institute, Emory University)
- Fadlo R. Khuri
(Emory University
Winship Cancer Institute, Emory University
Present address: American University of Beirut, Riyad El-Solh, Beirut 11072020, Lebanon)
- Haian Fu
(Emory University
Emory University
Winship Cancer Institute, Emory University)
Abstract
As genomics advances reveal the cancer gene landscape, a daunting task is to understand how these genes contribute to dysregulated oncogenic pathways. Integration of cancer genes into networks offers opportunities to reveal protein–protein interactions (PPIs) with functional and therapeutic significance. Here, we report the generation of a cancer-focused PPI network, termed OncoPPi, and identification of >260 cancer-associated PPIs not in other large-scale interactomes. PPI hubs reveal new regulatory mechanisms for cancer genes like MYC, STK11, RASSF1 and CDK4. As example, the NSD3 (WHSC1L1)–MYC interaction suggests a new mechanism for NSD3/BRD4 chromatin complex regulation of MYC-driven tumours. Association of undruggable tumour suppressors with drug targets informs therapeutic options. Based on OncoPPi-derived STK11-CDK4 connectivity, we observe enhanced sensitivity of STK11-silenced lung cancer cells to the FDA-approved CDK4 inhibitor palbociclib. OncoPPi is a focused PPI resource that links cancer genes into a signalling network for discovery of PPI targets and network-implicated tumour vulnerabilities for therapeutic interrogation.
Suggested Citation
Zenggang Li & Andrei A. Ivanov & Rina Su & Valentina Gonzalez-Pecchi & Qi Qi & Songlin Liu & Philip Webber & Elizabeth McMillan & Lauren Rusnak & Cau Pham & Xiaoqian Chen & Xiulei Mo & Brian Revennaug, 2017.
"The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies,"
Nature Communications, Nature, vol. 8(1), pages 1-14, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14356
DOI: 10.1038/ncomms14356
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14356. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.